A detailed history of Capital Fund Management S.A. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Capital Fund Management S.A. holds 15,500 shares of TEVA stock, worth $342,395. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,500
Previous 40,745 61.96%
Holding current value
$342,395
Previous $662,000 57.85%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$12.78 - $17.4 $1.88 Million - $2.56 Million
-147,169 Reduced 78.32%
40,745 $662,000
Q1 2024

May 15, 2024

SELL
$10.67 - $14.43 $3.34 Million - $4.51 Million
-312,633 Reduced 62.46%
187,914 $2.65 Million
Q4 2023

Feb 14, 2024

BUY
$8.12 - $10.63 $510,772 - $668,658
62,903 Added 14.37%
500,547 $5.23 Million
Q3 2023

Nov 14, 2023

SELL
$7.48 - $10.7 $6.91 Million - $9.89 Million
-924,149 Reduced 67.86%
437,644 $4.46 Million
Q2 2023

Aug 14, 2023

BUY
$7.2 - $9.47 $5.1 Million - $6.7 Million
707,901 Added 108.26%
1,361,793 $10.3 Million
Q1 2023

May 15, 2023

SELL
$8.36 - $11.37 $1.38 Million - $1.88 Million
-165,467 Reduced 20.19%
653,892 $5.79 Million
Q4 2022

Feb 13, 2023

SELL
$7.95 - $9.48 $941,065 - $1.12 Million
-118,373 Reduced 12.62%
819,359 $7.47 Million
Q3 2022

Nov 14, 2022

SELL
$6.86 - $11.95 $1.69 Million - $2.95 Million
-246,878 Reduced 20.84%
937,732 $7.57 Billion
Q2 2022

Aug 12, 2022

BUY
$7.38 - $10.4 $5.76 Million - $8.12 Million
780,973 Added 193.48%
1,184,610 $8.91 Million
Q1 2022

May 12, 2022

BUY
$7.33 - $9.39 $2.96 Million - $3.79 Million
403,637 New
403,637 $3.79 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.5B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Capital Fund Management S.A. Portfolio

Follow Capital Fund Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.